These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 10435807)

  • 21. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.
    Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation.
    Chen ET; Mohiuddin M; Brodovsky H; Fishbein G; Marks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):169-75. PubMed ID: 8083110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
    De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
    Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.
    Janjan NA; Crane CN; Feig BW; Cleary K; Dubrow R; Curley SA; Ellis LM; Vauthey J; Lenzi R; Lynch P; Wolff R; Brown T; Pazdur R; Abbruzzese J; Hoff PM; Allen P; Brown B; Skibber J
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):713-8. PubMed ID: 10837955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcome analysis.
    Calvo FA; Gómez-Espí M; Díaz-González JA; Alvarado A; Cantalapiedra R; Marcos P; Matute R; Martínez NE; Lozano MA; Herranz R
    Radiother Oncol; 2002 Feb; 62(2):201-6. PubMed ID: 11937247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy.
    Beresford M; Glynne-Jones R; Richman P; Makris A; Mawdsley S; Stott D; Harrison M; Osborne M; Ashford R; Grainger J; Al-Jabbour J; Talbot I; Mitchell IC; Meyrick Thomas J; Livingstone JI; McCue J; MacDonald P; Northover JA; Windsor A; Novell R; Wallace M; Harrison RA
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):448-55. PubMed ID: 16149289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
    Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
    Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.
    Moureau-Zabotto L; Farnault B; de Chaisemartin C; Esterni B; Lelong B; Viret F; Giovannini M; Monges G; Delpero JR; Bories E; Turrini O; Viens P; Salem N
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):483-91. PubMed ID: 21093174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
    Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
    Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
    J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
    Wiltshire KL; Ward IG; Swallow C; Oza AM; Cummings B; Pond GR; Catton P; Kim J; Ringash J; Wong CS; Wong R; Siu LL; Moore M; Brierley J
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):709-16. PubMed ID: 16242252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
    Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach.
    Biniaz M; Moradi A; Basit MG; Pashaki AS; Dehghan A; Mohammadian K
    BMC Cancer; 2024 Jul; 24(1):863. PubMed ID: 39026218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy?
    Chan AK; Wong AO; Jenken DA
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1413-9. PubMed ID: 20338475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer.
    Boskos CS; Liacos C; Korkolis D; Aygerinos K; Lamproglou I; Terpos E; Stoupa E; Baltatzis G; Beroukas K; Papasavvas P; Dimopoulos MA; Bamias A
    J Surg Oncol; 2010 Oct; 102(5):408-12. PubMed ID: 19877119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.